SEARCH

SEARCH BY CITATION

References

  • Allinson T. M., Parkin E. T., Turner A. J. and Hooper N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74, 342352.
  • Bodendorf U., Danner S., Fischer F., Stefani M., Sturchler-Pierrat C., Wiederhold K. H., Staufenbiel M. and Paganetti P. (2002) Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. J. Neurochem. 80, 799806.
  • Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P. and Black R. A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27 76527 767.
  • Cheng I. H., Palop J. J., Esposito L. A., Bien-Ly N., Yan F. and Mucke L. (2004) Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat. Med. 10, 11901192.
  • Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I. and Selkoe D. J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer’s disease increases β-protein production. Nature 360, 672674.
  • Davis J. and Van Nostrand W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc. Natl Acad. Sci. USA 93, 29963000.
  • Davis J., Xu F., Deane R., Romanov G., Previti M. L., Zeigler K., Zlokovic B. V. and Van Nostrand W. E. (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279, 20 29620 306.
  • De Strooper B. (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex. Neuron 38, 912.
  • Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H. and Haass C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486488.
  • Goate A., Chartier-Harlin M. C., Mullan M. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704706.
  • Grabowski T. J., Cho H. S., Vonsattel J. P., Rebeck G. W. and Greenberg S. M. (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49, 697705.
  • Haass C., Hung A. Y., Schlossmacher M. G., Teplow D. B. and Selkoe D. J. (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 30213024.
  • Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L. and Selkoe D. J. (1995) The Swedish mutation causes early-onset Alzheimer’s disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 12911296.
  • Hardy J. (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci. 20, 154159.
  • Hardy J. A. and Higgins G. A. (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184185.
  • Harper J. D., Wong S. S., Lieber C. M. and Lansbury P. T. (1997) Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119125.
  • Hendriks L., Van Duijn C. M., Cras P. et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet. 1, 218221.
  • Herzig M. C., Winkler D. T., Burgermeister P. et al. (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7, 954960.
  • Höglund K., Syversen S., Lewczuk P., Wallin A., Wiltfang J. and Blennow K. (2005) Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer’s disease. Exp. Brain Res. 164, 205214.
  • Jarrett J. T., Berger E. P. and Lansbury P. T., Jr (1993) The C-terminus of the beta protein is critical in amyloidogenesis. Ann. N. Y. Acad. Sci. 695, 144148.
  • Johansson A. S., Berglind-Dehlin F., Karlsson G., Edwards K., Gellerfors P. and Lannfelt L. (2006) Physiochemical characterization of the Alzheimer´s disease related peptides Aβ1-42 Arctic and Aβ1-42 Wt. FEBS J. 273, 26182630.
  • Johnson-Wood K., Lee M., Motter R. et al. (1997) Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 15501555.
  • Knobloch M., Konietzko U., Krebs D. C. and Nitsch R. M. (2006) Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol. Aging (in press).
  • Knops J., Suomensaari S., Lee M., McConlogue L., Seubert P. and Sinha S. (1995) Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J. Biol. Chem. 270, 24192422.
  • Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K. and Ishiura S. (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343 (pt 2), 371375.
  • Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C. and Fahrenholz F. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 39223927.
  • Lannfelt L., Basun H., Wahlund L. O., Rowe B. A. and Wagner S. L. (1995) Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer’s disease. Nat. Med. 1, 829832.
  • Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., Van Duinen S. G., Bots G. T., Luyendijk W. and Frangione B. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 11241126.
  • Lord A., Kalimo H., Eckman C., Zhang X. Q., Lannfelt L. and Nilsson L. N. (2006) The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol. Aging 27, 6777.
  • Maruyama K., Kametani F., Usami M., Yamao-Harigaya W. and Tanaka K. (1991) “Secretase,” Alzheimer amyloid protein precursor secreting enzyme is not sequence-specific. Biochem. Biophys. Res. Commun. 179, 16701676.
  • Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 42454249.
  • Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B. and Lannfelt L. (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345347.
  • Murakami K., Irie K., Morimoto A., Ohigashi H., Shindo M., Nagao M., Shimizu T. and Shirasawa T. (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer’s disease at positions 21-23. Biochem. Biophys. Res. Commun. 294, 510.
  • Näslund J., Schierhorn A., Hellman U. et al. (1994) Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl Acad. Sci. USA 91, 83788382.
  • Nilsberth C., Westlind-Danielsson A., Eckman C. B. et al. (2001) The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4, 887893.
  • Parvathy S., Hussain I., Karran E. H., Turner A. J. and Hooper N. M. (1999) Cleavage of Alzheimer’s amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells. Biochemistry 38, 97289734.
  • Postina R., Schroeder A., Dewachter I. et al. (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 14561464.
  • Selkoe D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol. 8, 447453.
  • Selkoe D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399, A23A31.
  • Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins and therapy. Physiol. Rev. 81, 741766.
  • Sisodia S. S. (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl Acad. Sci. USA 89, 60756079.
  • Skovronsky D. M., Moore D. B., Milla M. E., Doms R. W. and Lee V. M. (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-Golgi network. J. Biol. Chem. 275, 25682575.
  • Soto C., Castano E. M., Frangione B. and Inestrosa N. C. (1995) The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J. Biol. Chem. 270, 30633067.
  • Stenh C., Nilsberth C., Hammarbäck J., Engvall B., Näslund J. and Lannfelt L. (2002) The Arctic mutation interferes with processing of the amyloid precursor protein. Neuroreport 13, 18571860.
  • Stenh C., Englund H., Lord A., Johansson A. S., Almeida C. G., Gellerfors P., Greengard P., Gouras G. K., Lannfelt L. and Nilsson L. N. (2005) Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay. Ann. Neurol. 58, 147150.
  • Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L., Jr., Eckman C., Golde T. E. and Younkin S. G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 13361340.
  • Tagliavini F., Rossi G., Padovani A. et al. (1999) A new βPP mutation related to hereditary cerebral haemorrhage. Alzheimer’s Rep. 2, S28.
  • Van Broeckhoven C., Haan J., Bakker E., Hardy J. A., Van Hul W., Wehnert A., Vegter-Van der Vlis M. and Roos R. A. (1990) Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248, 11201122.
  • Vassar R., Bennett B. D., Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Walsh D. M., Lomakin A., Benedek G. B., Condron M. M. and Teplow D. B. (1997) Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22 36422 372.
  • Wilson C. A., Doms R. W. and Lee V. M.-Y. (1999) Intracellular APP processing and Aβ production in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 58, 787794.